SPX4,071.70-4.87 -0.12%
DIA344.74+0.33 0.10%
IXIC11,461.50-20.95 -0.18%

BRIEF-Court Approves Chemomab Therapeutics' Repurchase Arrangement With Co-Founders

Reuters · 11/16/2022 07:37
BRIEF-Court Approves Chemomab Therapeutics' Repurchase Arrangement With Co-Founders

- Chemomab Therapeutics Ltd CMMB.O:

  • CHEMOMAB THERAPEUTICS LTD- ON NOV 14,ECONOMIC COURT OF TEL-AVIV, ISRAEL, APPROVED CO'S PETITION TO ENTER INTO REPURCHASE ARRANGEMENT WITH CO-FOUNDERS

  • CHEMOMAB THERAPEUTICS LTD - INTENDS TO REPURCHASE ENTIRE AMOUNT OF 582,023 OF CO-FOUNDERS' ADSS FOR TOTAL CONSIDERATION OF ABOUT $1.2 MILLION

  • CHEMOMAB THERAPEUTICS LTD - CASH RUNWAY IS EXPECTED TO LAST THROUGH END OF 2023, CONSISTENT WITH LAST QUARTERLY UPDATE PROVIDED BY CO

  • CHEMOMAB THERAPEUTICS LTD - DOES NOT EXPECT ANY CHANGE IN ITS CASH RUNWAY AS A RESULT OF THE REPURCHASE ARRANGEMENT

Source text : (http://bit.ly/3UF9f8R)

Further company coverage: CMMB.O


((Reuters.Briefs@thomsonreuters.com;))